Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alx Oncology Holdings (ALXO) Gains from Investment Securities (2021 - 2026)

Alx Oncology Holdings' Gains from Investment Securities history spans 3 years, with the latest figure at $63000.0 for Q4 2023.

  • On a quarterly basis, Gains from Investment Securities fell 98.55% to $63000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $388000.0, a 95.13% decrease, with the full-year FY2025 number at $929000.0, down 64.27% from a year prior.
  • Gains from Investment Securities hit $63000.0 in Q4 2023 for Alx Oncology Holdings, down from $111000.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for ALXO hit a ceiling of $4.3 million in Q4 2022 and a floor of $63000.0 in Q4 2023.
  • Historically, Gains from Investment Securities has averaged $975595.0 across 3 years, with a median of $109000.0 in 2023.
  • Biggest five-year swings in Gains from Investment Securities: skyrocketed 4065.38% in 2022 and later plummeted 98.55% in 2023.
  • Tracing ALXO's Gains from Investment Securities over 3 years: stood at $104000.0 in 2021, then skyrocketed by 4065.38% to $4.3 million in 2022, then plummeted by 98.55% to $63000.0 in 2023.
  • Business Quant data shows Gains from Investment Securities for ALXO at $63000.0 in Q4 2023, $111000.0 in Q3 2023, and $107000.0 in Q2 2023.